Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Name:
36494221.pdf
Size:
994.4Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Gillessen, S.Bossi, A.
Davis, I. D.
de Bono, J.
Fizazi, K.
James, N. D.
Mottet, N.
Shore, N.
Small, E.
Smith, M.
Sweeney, C.
Tombal, B.
Antonarakis, E. S.
Aparicio, A. M.
Armstrong, A. J.
Attard, G.
Beer, T. M.
Beltran, H.
Bjartell, A.
Blanchard, P.
Briganti, A.
Bristow, Robert G
Bulbul, M.
Caffo, O.
Castellano, D.
Castro, E.
Cheng, H. H.
Chi, K. N.
Chowdhury, S.
Clarke, C. S.
Clarke, Noel W
Daugaard, G.
De Santis, M.
Duran, I.
Eeles, R.
Efstathiou, E.
Efstathiou, J.
Ngozi Ekeke, O.
Evans, C. P.
Fanti, S.
Feng, F. Y.
Fonteyne, V.
Fossati, N.
Frydenberg, M.
George, D.
Gleave, M.
Gravis, G.
Halabi, S.
Heinrich, D.
Herrmann, K.
Higano, C.
Hofman, M. S.
Horvath, L. G.
Hussain, M.
Alicja Jereczek-Fossa, B.
Jones, R.
Kanesvaran, R.
Kellokumpu-Lehtinen, P. L.
Khauli, R. B.
Klotz, L.
Kramer, G.
Leibowitz, R.
Logothetis, C. J.
Mahal, B. A.
Maluf, F.
Mateo, J.
Matheson, D.
Mehra, N.
Merseburger, A.
Morgans, A. K.
Morris, M. J.
Mrabti, H.
Mukherji, D.
Murphy, D. G.
Murthy, V.
Nguyen, P. L.
Oh, W. K.
Ost, P.
O'Sullivan, J. M.
Padhani, A. R.
Pezaro, C.
Poon, D. M. C.
Pritchard, C. C.
Rabah, D. M.
Rathkopf, D.
Reiter, R. E.
Rubin, M. A.
Ryan, C. J.
Saad, F.
Pablo Sade, J.
Sartor, O. A.
Scher, H. I.
Sharifi, N.
Skoneczna, I.
Soule, H.
Spratt, D. E.
Srinivas, S.
Sternberg, C. N.
Steuber, T.
Suzuki, H.
Sydes, M. R.
Taplin, M. E.
Tilki, D.
Türkeri, L.
Turco, F.
Uemura, H.
Uemura, H.
Ürün, Y.
Vale, C. L.
van Oort, I.
Vapiwala, N.
Walz, J.
Yamoah, K.
Ye, D.
Yu, E. Y.
Zapatero, A.
Zilli, T.
Omlin, A.
Affiliation
Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland.Issue Date
2022
Metadata
Show full item recordAbstract
Background: Innovations in imaging and molecular characterisation and the evolution of new therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue to lack high-level evidence on a variety of clinical topics that greatly impact daily practice. To supplement evidence-based guidelines, the 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) surveyed experts about key dilemmas in clinical management. Objective: To present consensus voting results for select questions from APCCC 2022. Design, setting, and participants: Before the conference, a panel of 117 international prostate cancer experts used a modified Delphi process to develop 198 multiple-choice consensus questions on (1) intermediate- and high-risk and locally advanced prostate cancer, (2) biochemical recurrence after local treatment, (3) side effects from hormonal therapies, (4) metastatic hormone-sensitive prostate cancer, (5) nonmetastatic castration-resistant prostate cancer, (6) metastatic castration-resistant prostate cancer, and (7) oligometastatic and oligoprogressive prostate cancer. Before the conference, these questions were administered via a web-based survey to the 105 physician panel members ("panellists") who directly engage in prostate cancer treatment decision-making. Herein, we present results for the 82 questions on topics 1-3. Outcome measurements and statistical analysis: Consensus was defined as ≥75% agreement, with strong consensus defined as ≥90% agreement. Results and limitations: The voting results reveal varying degrees of consensus, as is discussed in this article and shown in the detailed results in the Supplementary material. The findings reflect the opinions of an international panel of experts and did not incorporate a formal literature review and meta-analysis. Conclusions: These voting results by a panel of international experts in advanced prostate cancer can help physicians and patients navigate controversial areas of clinical management for which high-level evidence is scant or conflicting. The findings can also help funders and policymakers prioritise areas for future research. Diagnostic and treatment decisions should always be individualised based on patient and cancer characteristics (disease extent and location, treatment history, comorbidities, and patient preferences) and should incorporate current and emerging clinical evidence, therapeutic guidelines, and logistic and economic factors. Enrolment in clinical trials is always strongly encouraged. Importantly, APCCC 2022 once again identified important gaps (areas of nonconsensus) that merit evaluation in specifically designed trials.Citation
Gillessen S, Bossi A, Davis ID, de Bono J, Fizazi K, James ND, et al. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. Eur Urol. 2022 Dec 6. PubMed PMID: 36494221. Epub 2022/12/10. eng.Journal
European UrologyDOI
10.1016/j.eururo.2022.11.002PubMed ID
36494221Additional Links
https://dx.doi.org/10.1016/j.eururo.2022.11.002Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.eururo.2022.11.002
Scopus Count
Collections
Related articles
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
- Authors: Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A
- Issue date: 2020 Apr
- Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.
- Authors: Gillessen S, Armstrong A, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Bulbul M, Caffo O, Chi KN, Clarke CS, Clarke N, Davis ID, de Bono JS, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ekeke ON, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, George D, Gleave M, Halabi S, Heinrich D, Higano C, Hofman MS, Hussain M, James N, Jones R, Kanesvaran R, Khauli RB, Klotz L, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Rabah DM, Rathkopf D, Reiter RE, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Skoneczna I, Small E, Smith M, Soule H, Spratt DE, Sternberg CN, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tilki D, Tombal B, Türkeri L, Uemura H, Uemura H, van Oort I, Yamoah K, Ye D, Zapatero A, Omlin A
- Issue date: 2022 Jul
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
- Authors: Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung BH, Clarke N, Daugaard G, Davis ID, de Bono J, Borges Dos Reis R, Drake CG, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano CS, James N, Kantoff P, Kellokumpu-Lehtinen PL, Khauli RB, Kramer G, Logothetis C, Maluf F, Morgans AK, Morris MJ, Mottet N, Murthy V, Oh W, Ost P, Padhani AR, Parker C, Pritchard CC, Roach M, Rubin MA, Ryan C, Saad F, Sartor O, Scher H, Sella A, Shore N, Smith M, Soule H, Sternberg CN, Suzuki H, Sweeney C, Sydes MR, Tannock I, Tombal B, Valdagni R, Wiegel T, Omlin A
- Issue date: 2018 Feb
- Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings.
- Authors: Vogl UM, Beer TM, Davis ID, Shore ND, Sweeney CJ, Ost P, Attard G, Bossi A, de Bono J, Drake CG, Efstathiou E, Fanti S, Fizazi K, Halabi S, James N, Mottet N, Padhani AR, Roach M, Rubin M, Sartor O, Small E, Smith MR, Soule H, Sydes MR, Tombal B, Omlin A, Gillessen S, APCCC 2019 expert panel
- Issue date: 2022 Jan
- Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017.
- Authors: Saad M, Alip A, Lim J, Abdullah MM, Chong FLT, Chua CB, Ismail F, Khong RK, Lim CS, Loh CS, Malek R, Mohd Ghani KA, Md Noor I, Md Yusoff NA, Nasuha NA, Razack A, Soo Hoo HF, Sundram M, Tan HM, Thiagarajan M, Teh GC, Voon PJ, Ong TA
- Issue date: 2019 Sep